ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

ORIC Pharmaceuticals (Nasdaq: ORIC) announced management will participate in three investor conferences in November 2025: a fireside chat at Guggenheim’s 2nd Annual Healthcare Innovation Conference on Nov 11, 2025 at 1:30 p.m. ET, one-on-one meetings at Stifel 2025 Healthcare Conference on Nov 12, 2025, and a fireside chat at Jefferies London Healthcare Conference on Nov 19, 2025 at 2:30 p.m. GMT. Management will also hold one-on-one meetings at the Guggenheim and Jefferies events.

Webcasts of the fireside chats will be available via the company’s investor website and replays will remain available for 90 days following each event.

News Market Reaction – ORIC

+0.65%

+0.65% Session close to close

In the Nov 5 session, ORIC gained 0.65%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in November:

• Guggenheim’s 2nd Annual Healthcare Innovation Conference – Participating in a fireside chat on Tuesday, November 11, 2025, at 1:30 p.m. ET. Management will also be participating in one-on-one meetings.
  
• Stifel 2025 Healthcare Conference – Participating in one-on-one meetings on Wednesday, November 12, 2025.
  
• Jefferies London Healthcare Conference – Participating in a fireside chat on Wednesday, November 19, 2025, at 2:30 p.m. GMT. Management will also be participating in one-on-one meetings.
  

Webcasts of the fireside chat discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the embryonic ectoderm development (EED) subunit, being developed for prostate cancer, and (2) enozertinib (ORIC-114), a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:

Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com

FAQ

When will ORIC (ORIC) present at Guggenheim’s 2nd Annual Healthcare Innovation Conference?

ORIC will participate in a fireside chat on Nov 11, 2025 at 1:30 p.m. ET and will hold one-on-one meetings.

What is the date and time for ORIC’s Jefferies London Healthcare Conference fireside chat?

The fireside chat is scheduled for Nov 19, 2025 at 2:30 p.m. GMT.

How can investors watch ORIC’s conference fireside chats for ORIC?

Webcasts will be available through the company’s investor section on the corporate website and replays will be available for 90 days after each event.

Will ORIC management meet investors at the Stifel 2025 Healthcare Conference?

Yes. Management will participate in one-on-one meetings at the Stifel conference on Nov 12, 2025.

Where can I find replays of ORIC’s conference webcasts after the live events?

Replays are posted on the company’s investor website and remain available for 90 days following each event.